Literature DB >> 16639495

MR evaluation of pulmonary vein diameter reduction after radiofrequency catheter ablation of atrial fibrillation.

Frédéric Anselme1, Gérald Gahide, Arnaud Savouré, Edouard Gerbaud, Mikael Mabru, Alain Cribier, Jean-Nicolas Dacher.   

Abstract

Fifty consecutive patients aged 52+/-12 years suffering from drug refractory atrial fibrillation (AF) underwent baseline and post-ablation MR angiography (MRA) at a mean follow-up of 4+/-3.5 months. Pulmonary vein (PV) disconnection was performed with a maximum energy delivery of 30 W. MRA allowed a two-plane measurement of each PV ostium. After ablation, no significant stenosis was observed, and only 1/194 (0.5%) and 3/194 (2%) PVs had a diameter reduction of 31-40% in the coronal and axial planes, respectively. There was a significant overall post-procedural PV narrowing of 4.9% in the coronal plane and 6.5% in the axial plane (P=ns between both planes). MRA is an efficient technique that can be used in pre- and postoperative evaluation of AF patients. Using a maximal power delivery limited to 30 W, no significant PV stenosis was observed at mid-term follow-up. Late PV anatomical assessment is needed to confirm these results on long-term follow-up.

Entities:  

Mesh:

Year:  2006        PMID: 16639495     DOI: 10.1007/s00330-006-0252-z

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  20 in total

1.  Pulmonary vein stenosis after radiofrequency ablation of atrial fibrillation: functional characterization, evolution, and influence of the ablation strategy.

Authors:  Eduardo B Saad; Antonio Rossillo; Cynthia P Saad; David O Martin; Mandeep Bhargava; Demet Erciyes; Dianna Bash; Michelle Williams-Andrews; Salwa Beheiry; Nassir F Marrouche; James Adams; Ennio Pisanò; Raffaele Fanelli; Domenico Potenza; Antonio Raviele; Aldo Bonso; Sakis Themistoclakis; Joannes Brachmann; Walid I Saliba; Robert A Schweikert; Andrea Natale
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

2.  Atrial electroanatomic remodeling after circumferential radiofrequency pulmonary vein ablation: efficacy of an anatomic approach in a large cohort of patients with atrial fibrillation.

Authors:  C Pappone; G Oreto; S Rosanio; G Vicedomini; M Tocchi; F Gugliotta; A Salvati; C Dicandia; M P Calabrò; P Mazzone; E Ficarra; C Di Gioia; S Gulletta; S Nardi; V Santinelli; S Benussi; O Alfieri
Journal:  Circulation       Date:  2001-11-20       Impact factor: 29.690

3.  Atrial fibrillation: multi-detector row CT of pulmonary vein anatomy prior to radiofrequency catheter ablation--initial experience.

Authors:  Monique R M Jongbloed; Martijn S Dirksen; Jeroen J Bax; Eric Boersma; Koos Geleijns; Hildo J Lamb; Ernst E van der Wall; Albert de Roos; Martin J Schalij
Journal:  Radiology       Date:  2005-01-21       Impact factor: 11.105

4.  Electrophysiological breakthroughs from the left atrium to the pulmonary veins.

Authors:  M Haïssaguerre; D C Shah; P Jaïs; M Hocini; T Yamane; I Deisenhofer; M Chauvin; S Garrigue; J Clémenty
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

5.  A focal source of atrial fibrillation treated by discrete radiofrequency ablation.

Authors:  P Jaïs; M Haïssaguerre; D C Shah; S Chouairi; L Gencel; M Hocini; J Clémenty
Journal:  Circulation       Date:  1997-02-04       Impact factor: 29.690

6.  Pulmonary vein isolation for paroxysmal and persistent atrial fibrillation.

Authors:  Hakan Oral; Bradley P Knight; Hiroshi Tada; Mehmet Ozaydin; Aman Chugh; Sohail Hassan; Christoph Scharf; Steve W K Lai; Radmira Greenstein; Frank Pelosi; S Adam Strickberger; Fred Morady
Journal:  Circulation       Date:  2002-03-05       Impact factor: 29.690

Review 7.  Percutaneous ablation for atrial fibrillation: the role of cross-sectional imaging.

Authors:  Benoit Ghaye; David Szapiro; Jean-Nicolas Dacher; Luz-Maria Rodriguez; Carl Timmermans; David Devillers; Robert F Dondelinger
Journal:  Radiographics       Date:  2003-10       Impact factor: 5.333

8.  Pulmonary vein stenosis by ostial irrigated-tip ablation: incidence, time course, and prediction.

Authors:  Helmut Pürerfellner; Rudolf Cihal; Josef Aichinger; Martin Martinek; Hans Joachim Nesser
Journal:  J Cardiovasc Electrophysiol       Date:  2003-02

9.  Pulmonary vein stenosis after catheter ablation of atrial fibrillation.

Authors:  I M Robbins; E V Colvin; T P Doyle; W E Kemp; J E Loyd; W S McMahon; G N Kay
Journal:  Circulation       Date:  1998-10-27       Impact factor: 29.690

10.  Pulmonary vein ostium geometry: analysis by magnetic resonance angiography.

Authors:  Fred H M Wittkampf; Evert-Jan Vonken; Richard Derksen; Peter Loh; Birgitta Velthuis; Eric F D Wever; Lucas V A Boersma; Benno J Rensing; Maarten-Jan Cramer
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

View more
  4 in total

1.  Precision of pulmonary vein diameter measurements assessed by CE-MRA and steady-state-free precession imaging.

Authors:  Michael Groth; Peter Bannas; Marc Regier; Jan H Buhk; Kai Müllerleile; Gerhard Adam; Frank O Henes
Journal:  Eur Radiol       Date:  2012-12-20       Impact factor: 5.315

2.  Pulmonary Vein Remodeling Following Atrial Fibrillation Ablation: Implications For The Radiographic Diagnosis Of Pulmonary Vein Stenosis.

Authors:  Faisal M Merchant; Mathew R Levy; Shahriar Iravanian; Ramal M Weragoda; Edward C Clermont; Heval M Kelli; Robert L Eisner; David Vadnais; Mikhael F El-Chami; Angel R Leon; David B Delurgio
Journal:  J Atr Fibrillation       Date:  2016-08-31

Review 3.  The State of the Art in Pulmonary Vein Stenosis -Diagnosis & Treatment.

Authors:  Lourdes R Prieto
Journal:  J Atr Fibrillation       Date:  2010-01-01

4.  Pulmonary vein morphology by free-breathing whole heart magnetic resonance imaging at 3 Tesla versus breathhold multi-detector computed tomography.

Authors:  Eszter Fodi; Dorothea McAreavey; Khaled Z Abd-Elmoniem; Jacques Ohayon; Magdi Saba; Abdalla Elagha; Roderic I Pettigrew; Ahmed M Gharib
Journal:  J Magn Reson Imaging       Date:  2012-11-21       Impact factor: 4.813

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.